Literature DB >> 22925504

Hypoxia inducible factor-1α-mediated activation of survivin in cervical cancer cells.

Haitao Bai1, Shengfang Ge, Jian Lu, Guanxiang Qian, Rang Xu.   

Abstract

AIM: Hypoxia, a characteristic of almost all types of solid tumors, has been associated with poor outcome in a number of human malignancies. The aim of this study was to investigate the molecular mechanisms involved in hypoxia-induced activation of the human survivin gene promoter in cervical HeLa cells.
MATERIAL AND METHODS: Immunohistochemical staining was used to detect the expression of HIF-1α and survivin in cervical cancer samples and normal cervical samples. Under normoxic and hypoxic conditions, the expression of hypoxia inducible factor (HIF)-1α and survivin in cervical cancer HeLa cells was detected by quantitative reverse transcription polymerase chain reaction and Western blotting. Luciferase reporter assays was used to investigate the molecular mechanisms in hypoxia-induced survivin activation. We also studied the effect of HIF-1α overexpression on the expression of survivin in cervical cancer HeLa cells.
RESULTS: Significant HIF-1α and survivin overexpression is associated with cervical cancer, and HIF-1α protein expression is strongly correlated with survivin protein expression. In cervical cancer cell line (HeLa), hypoxia upregulated both HIF-1α and survivin expression. Moreover, luciferase reporter assays using survivin core promoter demonstrated that survivin transcription was activated under hypoxia conditions and was associated with HIF-1α overexpression. The transcriptional activation of reporter genes in response to hypoxia is independent of potential HIF-1α-responsive element, located between -86 and -82 regions. HIF-1α overexpression significantly activated survivin expression.
CONCLUSION: Our results demonstrate that survivin expression is upregulated following the induction of HIF-1α by hypoxia resulting from tumor formation, possibly leading to tumor progression. These findings have potential implication in developing novel cancer therapy targeting HIF-1.
© 2012 The Authors. Journal of Obstetrics and Gynaecology Research © 2012 Japan Society of Obstetrics and Gynecology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22925504     DOI: 10.1111/j.1447-0756.2012.01995.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  12 in total

1.  Clinicopathological significance of survivin expression in patients with cervical cancer: A systematic meta-analysis.

Authors:  Yibing Fan; Juan Chen
Journal:  Bioengineered       Date:  2017-01-04       Impact factor: 3.269

2.  Yin Yang 1 regulates the transcriptional repression of Survivin.

Authors:  Nicholas R Galloway; Carlos J Diaz Osterman; Karl Reiber; Jessica M S Jutzy; Fengzhi Li; Guangchao Sui; Ubaldo Soto; Nathan R Wall
Journal:  Biochem Biophys Res Commun       Date:  2014-02-04       Impact factor: 3.575

3.  Survivin contributes to the progression of diabetic retinopathy through HIF-1α pathway.

Authors:  Ningning Liu; Ning Zhao; Lei Chen; Na Cai
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

4.  Role of hypoxia-inducible factor-1α and survivin in oxygen-induced retinopathy in mice.

Authors:  Ningning Liu; Yizhou Sun; Ning Zhao; Lei Chen
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

5.  Candidate biomarkers for cervical cancer treatment: Potential for clinical practice (Review).

Authors:  Miho Iida; Kouji Banno; Megumi Yanokura; Kanako Nakamura; Masataka Adachi; Yuya Nogami; Kiyoko Umene; Kenta Masuda; Iori Kisu; Takashi Iwata; Kyoko Tanaka; Daisuke Aoki
Journal:  Mol Clin Oncol       Date:  2014-06-23

Review 6.  Yin Yang 1 (YY1): Regulation of Survivin and Its Role In Invasion and Metastasis.

Authors:  Nicholas R Galloway; Kathryn F Ball; TessaRae Stiff; Nathan R Wall
Journal:  Crit Rev Oncog       Date:  2017

7.  Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer.

Authors:  Arlene E Garcia-Soto; Nathalie D McKenzie; Margaret E Whicker; Joseph M Pearson; Edward A Jimenez; Lorraine Portelance; Jennifer J Hu; Joseph A Lucci; Rehman Qureshi; Andrew Kossenkov; Lauren Schwartz; Gordon B Mills; Amit Maity; Lilie L Lin; Fiona Simpkins
Journal:  Cancer       Date:  2021-05-01       Impact factor: 6.860

Review 8.  Survivin and Tumorigenesis: Molecular Mechanisms and Therapeutic Strategies.

Authors:  Xun Chen; Ning Duan; Caiguo Zhang; Wentao Zhang
Journal:  J Cancer       Date:  2016-01-10       Impact factor: 4.207

9.  Adipocyte-activated oxidative and ER stress pathways promote tumor survival in bone via upregulation of Heme Oxygenase 1 and Survivin.

Authors:  Mackenzie K Herroon; Erandi Rajagurubandara; Jonathan D Diedrich; Elisabeth I Heath; Izabela Podgorski
Journal:  Sci Rep       Date:  2018-01-08       Impact factor: 4.379

Review 10.  The Lipid Side of Bone Marrow Adipocytes: How Tumor Cells Adapt and Survive in Bone.

Authors:  Jonathan D Diedrich; Mackenzie K Herroon; Erandi Rajagurubandara; Izabela Podgorski
Journal:  Curr Osteoporos Rep       Date:  2018-08       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.